Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)

Frank Griesinger, Dimitri Flieger, Wolfgang M. Brueckl et al.|JTO Clinical and Research Reports|2023

Cited by 4